Denosumab is a human IgG2 monoclonal antibody used to treat bone problems that may occur with cancer that has spread (metastasized) to the bones. Denosumab is available under the following different brand names: Jubbonti, Prolia, Wyost, and Xgeva.

May 2, 2024 · Prolia (denosumab) is a monoclonal antibody used to treat bone loss (osteoporosis) in women who are at high risk for bone fracture after menopause. What Are Side Effects of Prolia? Prolia may cause serious side effects including: Get medical help right away, if you have any of the symptoms listed above. Common side effects of Prolia include:

4 days ago · Osenvelt (denosumab-bmwo) is a RANK ligand (RANKL) inhibitor indicated for prevention of skeletal-related events in patients with multiple myeloma and in patients with bone metastases from solid tumors, treatment of adults and skeletally mature adolescents with giant cell tumor of bone that is unresectable or where surgical resection is likely ...

Mar 10, 2025 · Prolia (denosumab) is an injection that is administered subcutaneously (under the skin) once every 6 months by a healthcare provider to: Increase bone mass in women at high risk for fracture receiving adjuvant aromatase inhibitor therapy for breast cancer. Bone is always breaking down and reforming.

Mar 1, 2025 · Denosumab injection is used to treat osteoporosis (thinning of the bones) in women who have an increased risk for fractures after menopause, and osteoporosis in men. It is given when other medicines cannot be used or after other medicines did not work well.

Denosumab is a human monoclonal antibody that works by inhibiting RANKL (receptor activator of nuclear factor kappa-B ligand), a protein essential for osteoclasts' formation, function, and survival. By inhibiting RANKL, denosumab decreases bone resorption and …

Prolia® injection is a brand of denosumab, which treats osteoporosis. Osteoporosis is a condition that weakens your bones, making them more susceptible to fractures. Xgeva® is another brand of denosumab that treats high calcium levels caused by cancer and prevents bone breaks.

Denosumab is a lab-made human monoclonal immunoglobulin G2 (IgG2) antibody medication used to reduce bone loss in patients at high risk for bone fractures due to postmenopausal osteoporosis, cancers or other conditions.

Dec 13, 2022 · Xgeva (denosumab) Injection is a human IgG2 monoclonal antibody used to treat bone problems that may occur with cancer that has spread (metastasized) to the bones. What Are Side Effects of Xgeva? Xgeva may cause serious side effects including: Get medical help right away, if you have any of the symptoms listed above.

Jan 16, 2025 · Detailed Denosumab dosage information for adults and children. Includes dosages for Osteoporosis, Osteolytic Bone Metastases of Solid Tumors, Hypercalcemia of Malignancy and more; plus renal, liver and dialysis adjustments.